Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nevermind??
LOL. Zagdad is the king of jumping on board scams and defending them to the death. How many suckers did you convince to buy this POS? Surprised to not see much of you on the other boards since news of the same sort broke out there.
new here but a qwik qwestion... is this the same curtis wenzlaff that was associated w/ the major league baseball steroids scandal? i.e. roger clemens etc...
ipex came out of the box as a voip company hq in socal where it died. via a reverse merger into a pink sheet shell it also tried solar panels but they were not competative so we slide into chinese neutraceuticals..............followed by another segway into solar panels. shells are shells and look for an inhabitant. maybe this time a low cost, viable homeowner friendly system will succeed........beats convolution
IPEX - Hey NEWS!! Looks like Salus Labs has something of siginificant interest on their plate concerning solar products....guess you wouldn't put out news about such things if you weren't serious in your efforts to get it going. Might have to spread the word on this little known, low OS share opportunity.
zagdad
Up 150% with some volume!! Yippee!! Another one of those low, I mean LOW, OS counts for a emerging business....but just no one has found them yet....the tree falling in the forest does make noise doesn't it....maybe some lucky investor with the radar tuned correctly or the crystal ball recently dusted will find Salus....somebody seems to be accumluating.
zagdad
A nice day for what ever reason! Bring us more!
zagdad
Good luck pulling your name out of the mud now Gary. LOL
Hey, my portfolio value on this one doubled today!!
Go Salus Labs! A steal here.
zagdad
Gary Patterson is the IR guy. I can't believe a PR with his name attached. He works for scam artists.
Yeah look at their latest news. THink about all the people in China drinking their sanctioned energy drink!! Can you say massive revenue stream??? Plenty more to come with this one and I see some dumb aass sold 10,000 shares @.05?? Now that is moronic!
Stay tuned......as this one looks like a gas soaked log ready to go higher with such a low float and small outstanding shares!!
Sorry but I think you are wrong on this one. A large deal with the government of China to produce all sorts of products and not just the White Tiger drink. Watch this thing hum along and at the current price I think it is a steal with such a low float!!! Any spark and this goes to .50 in a heartbeat. Just my humble opinion!!
Now that is some big news!!!
Salus Labs International Signs China Agreement
8:30a ET February 15, 2011 (Market Wire)
Salus Labs will launch "White Tiger Energy Blast" as its first product for the Chinese market. The energy formula will be modified to appeal to Chinese taste. Chongqing Pharmaceutical will formulate a specialized quick energy drink "for the Chinese, by the Chinese."
Chongquing will produce, market, and sell White Tiger throughout China, as well as introduce it into other Asian countries. Through the Project Cooperation/Development Agreement, Salus Labs International is approved to introduce additional nutrition and cosmetic products to the most populated country in the world, totaling over 1.3 billion people.
President and CEO Art Wenzlaff remarked, "We are elated at the potential our Agreement offers. Having a Chinese government-backed affiliation of companies as a working partner, offers our startup company a very bright future. We are now able to tap into a much coveted and exclusive market, that quite frankly, is not easily accessible to other companies."
The signing of Salus Labs Project Cooperation/Development Agreement is not merely ceremonial, as Chongqing, working through the Chinese government, has already filed the initial paperwork for the release of White Tiger Energy Blast. These Foundational steps constitute a landmark event in the growth of Salus Labs International.
Notice on Forward-Looking Statements: The matters set forth in this press release may contain forward-looking statements regarding Salus Labs and its business within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date on which they are made and Salus Labs undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Statements are subject to risks and uncertainties that may cause actual results to differ materially.
For Information Contact:
Investor relations
Gary Patterson
ir@saluslabs.com
714-369-2933
I'm in and staying in - the last PR gave good indications that we get some substamce/update soon. The float is so low that any action right now either way moves it...a lot more space above here for pps growth that there is down side risk IMO. Way too quiet here.
zagdad
Agreed - I'm a life-long weightlifting enthusiast, and very much into health-supporting food supplements, so I have an especially strong interest in seeing what products the company will be introducing. Sounds like they might have something special here. Nice to be on the ground floor. Thanks for the mark - one for you as well.
Welcome....and for your generosity I will grant you a people mark.
Looks like a great shell which has an interesting company moving in and setting up house... love the low OS.
zagdad
Just signed on with a board mark - thinking that this may come to life before too long.
News...looks like they are continuing to move forward.....
Salus Labs International Announces Initial Financing
Salus Labs Internati (USOTC:IPEX)
Intraday Stock Chart
Today : Wednesday 22 December 2010
Salus Labs International, Inc. (PINKSHEETS: IPEX) is pleased to announce that the first round of financing by a Private Investment Fund has been secured and received. This private infusion of capital now secures Salus Labs' ability to move to the next phase of product development. Although originally set for release in the last quarter of 2010, additional development as well as market research was conducted to better ensure a successful introduction into the market place. Salus' first product, a revolutionary anti-aging compound, is expected to be released in the first quarter 2011.
The company intends to develop, produce, and market high-quality nutritional supplements and anti-aging products. Salus Labs has initially defined its target market as the over-35 age group. Generally, this population values good health, and will become loyal customers to high-quality nutrition and fitness products that produce the desired results. The company will focus on the issues of aging and the sustainment of improved long-term health and fitness.
To date, while clinical testing of several products continues, the anti-aging product to be introduced in the coming months has shown remarkable results. Another product undergoing testing will focus on the vast number of people world-wide who are either directed to or prefer to lower body weight and/or cholesterol levels.
Art Wenzlaff, CEO, indicates, "Our company is in the right place at the right time for major contributions to the health and fitness industry. Our intention is to produce unique, one-of-a-kind products which will create their own demand. 'Better Living Through Chemistry,' the credo of our scientific staff, is the guide-post to our mission of improving customer quality of life. Through the anticipated success of these products corporate growth and shareholder value will significantly improve. Securing this initial funding allows our company to return to our original production schedule."
- The company expects to continue its plans previously announced to:
Provide additional information about products as they are released.
- The company intends to become fully reporting as quickly as possible.
- A corporate web site is expected to be developed and operational during first quarter of 2011. The company intends to keep the site current, transparent, and provide an effective means for communications between management, its shareholders, and the investment community.
About Salus Labs, International, Inc.
Salus Labs, International, Inc., a Nevada Corporation, is focused primarily on the research, development, production, and marketing of high-quality nutritional supplements and anti-aging products. It currently trades on the OTC Markets as IPEX.PK.
Notice on Forward-Looking Statements:
The matters set forth in this press release may contain forward-looking statements regarding Salus Labs and its business within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date on which they are made and Salus Labs undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Statements are subject to risks and uncertainties that may cause actual results to differ materially.
For Information Contact:
Investor relations
Gary Patterson
ir@saluslabs.com
714-369-2933
Somebody bury this stock. It's been dead for so long that it's starting to stink up the place.
Hmmm, looks like we need to get this IBox updated for anyone who wants to know what we own these days.
zagdad
holding up nicely dont look to be a greedy company. not diluting here. looks like a buy n hold for a while witch is rare in pinkyland.
Big surprise. Trying to pump up a reboot to a scam stock formed by Ault. Wouldn't be surprised to see you on his payroll the way you show a deep vested interest in most of his crap stocks.
Mod, assistant,
Can we get the ibox updated? maybe get the Informative pr made into a stickie? This wekend maybe I will try to get some visitors but right now it would catch any attention.
Seems we have a little gem here but thought to be a dead shell. Any ideas by the few others as to how to get the word out?
TIA, zagdad
FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 31, 2010
SALUS LABS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Nevada
(State or Other Jurisdiction
of Incorporation) 000-50774
(Commission File
Number) 41-2052984
(I.R.S. Employer
Identification Number)
1802 Hampden Road, Flint, MI 48503
(Address of principal executive offices) (zip code)
(810) 845-5000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
[Missing Graphic Reference]
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On March 31, 2010, IPEX, Inc. filed an amendment to its Articles of Incorporation with the Secretary of State of Nevada changing its corporate name from IPEX, Inc. to Salus Labs International, Inc. . FINRA approved this name change on August 12, 2010. Salus Labs International, Inc. will continue to trade under the same symbol as before, IPEX.
Item 5.02 - Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On August 13, 2010, Mr Curtis Wenzlaff resigned as President and CEO. He will remain on as a Director and Chairman of the Board. Mr. Art Wenzlaff accepted on August 13, 2010 the positions of President and CEO and remains a Director of the company.
.
1
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Salus Labs International, Inc.
Dated: August 23, 2010 By: /s/ Art Wenzlaff
Name: Art Wenzlaff
Title: Chief Executive Officer
2
a PR after years of sleep.......nice....new ballgame with a low OS and float.
Salus Labs Announces New Name, New Business Model, New Management
Salus Labs International, Inc.Common Stock (USOTC:IPEX)
Intraday Stock Chart
Today : Tuesday 31 August 2010
Salas Labs International, Inc. (PINKSHEETS: IPEX) is pleased to announce today the company has embarked on a new business model, a change of name from IPEX, Inc. to Salas Labs International, and new leadership. After nearly two years of research, development, and testing, Salus Labs is making a major shift into the health, nutrition, and fitness markets, under the guidance of new CEO Art Wenzlaff.
The company intends to develop, produce, and market high-quality nutritional supplements and anti-aging products. Salus Labs has initially defined its target market as the over-35 age group. Generally, this population values good health, and will become loyal customers to high-quality nutrition and fitness products that produce the desired results. The company will focus on the issues of aging and the sustainment of improved long-term health and fitness.
It is expected that one or more products will be released in 2010. To date, while clinical testing of several products continues, an anti-aging product has shown rather remarkable results. Another product undergoing testing will focus on the vast number of people, world-wide, who are either directed to, or prefer to, lower body weight and/or cholesterol levels.
Art Wenzlaff, CEO, indicates, "Our company is in the right place at the right time for major contributions to the health and fitness industry. Our intention is to produce unique, one-of-a-kind products, which will create their own demand. 'Better Living Through Chemistry,' the credo of our scientific staff, is the guide post to our mission of improving the quality of life of our customers. Through the success of these products corporate growth and shareholder value will significantly improve."
Additional information will be forthcoming including initial product release, clinical test results, product development, expansion plans and initiation of the corporate web site. During the last quarter of 2010 the company intends to be operational and revenue producing.
Additional business activities
-- Salus Labs principle management team includes:
- Art Wenzlaff, PhD, President and CEO
Art's experience includes many years as a public school
administrator with a strong background in organization and
administration, compliance, grant writing, public relations,
marketing, advertising, and media relations. These skills play
a significant role for the company and the products that it is
bringing to market.
- Curtis Wenzlaff, consultant and COB
Curt is very experienced in creating and nurturing business alliances. He has successfully developed both U.S. and
international business relationships with businesses and individuals who are influential in the health care industry and health care professionals who share similar interests.
-- Share structure at August 19, 2010:
Common
------
Auth 75,000,000
OS 15,234,565
Float 4,921,291
Preferred None
-- Corporate Headquarters expects to move to Las Vegas, NV, later this year. Current address is: 1802 Hampden Road, Flint, MI 48503
-- The company intends to become fully reporting as quickly as possible.
-- With respect to a symbol change, as of June 1, 2010, FINRA has adopted a policy of not accommodating requests for a change in the trading symbol until further notice. FINRA has indicated that a new policy for symbol changes will be released later this year and at that time Salus Labs will consider the possibility. Therefore, for the near future, shareholders can expect that the symbol "IPEX" will continue to be used.
-- The corporate web site is expected to be developed and operational by late September. The company intends to keep the site current, transparent, and provide an effective means for communications between management, its shareholders, and the investment community.
-- The company's IR contact is Gary Patterson. To insure prompt response the company encourages questions and comments be directed to Gary at ir@saluslabs.com or 714-369-2933.
About Salus Labs, International, Inc.
Salus Labs, International, Inc., a Nevada Corporation, is focused primarily on the research, development, production, and marketing of high-quality nutritional supplements and anti-aging products. It currently trades on the OTC Markets as IPEX.PK.
Notice on Forward-Looking Statements:
The matters set forth in this press release may contain forward-looking statements regarding Salas Labs and its business within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date on which they are made and Salas Labs undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Statements are subject to risks and uncertainties that may cause actual results to differ materially.
For Information Contact:
Investor relations
Gary Patterson
ir@saluslabs.com
714-369-2933
Hmm, a wake up call late last week...anybody notice...an 8K....
So thin, lookin' good......and almost a totally unknown company coming back to life it appears.
zagdad
HEY! No buying until I get more powder and buy some shares.....LOL!
sweet thanks iron. ya i need some anti aging drugs for my ol lady. lol Ill help ya out here no problem thanks again iron.
I'd love to get some anti-aging drugs for my knees.
This seems interesting. The low share count has got me intrigued. I usually play the sub penny. I'll have to do more research before I get in on IPEX.
and there it is
13:09 8/12/2010 IPEX IPEX, Inc. Common Stock IPEX Salus Labs International, Inc.Common Stock **
Soon baby!
Sounds good !
NAME CHANGE ANY DAY NOW.
VERY EXCITING BUSINESS TO BECOME IPEX.
SALUS LABS INTL.
CHECKOUT THE GUY WHO RUNS IT. MAJOT BACKGROUND.
ON 14.7 MILLION OUTSTANDING 5.4 MILLION IN FLOAT.
VERY FEW SHARES
GO IPEX
updated pink sheets info
looks like you right !
Now could we get a PR please ?
SLI is a health, nutrition and fitness company whose primary mission is to create and product high quality nutrition supplements and anti-aging products.
in my opinion that's the one.
there may be a connection between a major stock holder from the voip ipex to the salus ipex.
i'm just sayin'
check it out
punch in shopsalus.com
lotions and cremes
ipex was a shell looking for a reverse merger
the solar deal died as it became non viable due to chinese cost
I did find a company called salus that makes solar heating systems, not in America yet, might have something to do with IPEX
we do know that the CEO is in the solar business--so maybe
http://www.salus-controls.com/eng/news/news_detail.php?id=3&type_id=5
Friday 30 . October 2009
Entering the stockmarket (IPO)
Computime Ltd. is listed on the Hong Kong stockmarket. 25% of the issue will be in shares, yet the majority remains in family ownership
..................................................................
Salus is owned by Computime
Maybe they want to trade as an American company or maybe we will be America's distributors
..................................................................
http://www.linkedin.com/pub/curt-wenzlaff/10/661/689
Curt Wenzlaff’s Summary from linked in
I have very strong ties into China. Chances are very good that I can provide any given product at a reduced cost.
Curt Wenzlaff’s Specialties:
Solar panels and modules. Cement. Steel. Clothing. Surgical equipment.
looked thin into the close, today's knockdown was BS,,,shares are thin, imo.
HOD close,,,very nice.
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
98
|
Created
|
08/07/09
|
Type
|
Free
|
Moderators |
A new beginning with a very low share count, low float, new management, and new business in the health, nutrition, and fitness markets
Company Profile:
Salus Labs, International, Inc., a Nevada Corporation, is focused primarily on the research, development, production, and marketing of high-quality nutritional supplements and anti-aging products.
Salus Labs Announces New Name, New Business Model, New Management
LAS VEGAS, NV, Aug 31, 2010 (MARKETWIRE via COMTEX) -- Salas Labs International, Inc. (PINKSHEETS: IPEX) is pleased to announce today the company has embarked on a new business model, a change of name from IPEX, Inc. to Salas Labs International, and new leadership. After nearly two years of research, development, and testing, Salus Labs is making a major shift into the health, nutrition, and fitness markets, under the guidance of new CEO Art Wenzlaff.
The company intends to develop, produce, and market high-quality nutritional supplements and anti-aging products. Salus Labs has initially defined its target market as the over-35 age group. Generally, this population values good health, and will become loyal customers to high-quality nutrition and fitness products that produce the desired results. The company will focus on the issues of aging and the sustainment of improved long-term health and fitness.
It is expected that one or more products will be released in 2010. To date, while clinical testing of several products continues, an anti-aging product has shown rather remarkable results. Another product undergoing testing will focus on the vast number of people, world-wide, who are either directed to, or prefer to, lower body weight and/or cholesterol levels.
Art Wenzlaff, CEO, indicates, "Our company is in the right place at the right time for major contributions to the health and fitness industry. Our intention is to produce unique, one-of-a-kind products, which will create their own demand. 'Better Living Through Chemistry,' the credo of our scientific staff, is the guide post to our mission of improving the quality of life of our customers. Through the success of these products corporate growth and shareholder value will significantly improve."
Additional information will be forthcoming including initial product release, clinical test results, product development, expansion plans and initiation of the corporate web site. During the last quarter of 2010 the company intends to be operational and revenue producing.
Additional business activities
-- Salus Labs principle management team includes:
- Art Wenzlaff, PhD, President and CEO
Art's experience includes many years as a public school administrator with a strong background in organization and administration, compliance, grant writing, public relations,
marketing, advertising, and media relations. These skills play a significant role for the company and the products that it is bringing to market.
- Curtis Wenzlaff, consultant and COB
Curt is very experienced in creating and nurturing business alliances. He has successfully developed both U.S. and international business relationships with businesses and
individuals who are influential in the health care industry and health care professionals who share similar interests.
--- Share structure at August 19, 2010:
Common
Auth 75,000,000
OS 15,234,565
Float 4,921,291
Preferred None
-- Corporate Headquarters expects to move to Las Vegas, NV, later this year. Current address is: 1802 Hampden Road, Flint, MI 48503
-- The company intends to become fully reporting as quickly as possible.
-- With respect to a symbol change, as of June 1, 2010, FINRA has adopted a policy of not accommodating requests for a change in the trading symbol until further notice. FINRA has indicated that a new policy for symbol changes will be released later this year and at that time Salus Labs will consider the possibility. Therefore, for the near future, shareholders can expect that the symbol "IPEX" will continue to be used.
-- The corporate web site is expected to be developed and operational by late September. The company intends to keep the site current, transparent, and provide an effective means for communications between management, its shareholders, and the investment community.
-- The company's IR contact is Gary Patterson. To insure prompt response the company encourages questions and comments be directed to Gary at ir@saluslabs.com or 714-369-2933.
About Salus Labs, International, Inc.
Salus Labs, International, Inc., a Nevada Corporation, is focused primarily on the research, development, production, and marketing of high-quality nutritional supplements and anti-aging products. It currently trades on the OTC Markets as IPEX.PK.
Notice on Forward-Looking Statements:
The matters set forth in this press release may contain forward-looking statements regarding Salas Labs and its business within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date on which they are made and Salas Labs undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Statements are subject to risks and uncertainties that may cause actual results to differ materially.
For Information Contact:
Investor relations
Gary Patterson
ir@saluslabs.com
714-369-2933
*************************************************
Pinks Sheets info link http://www.otcmarkets.com/stock/IPEX/company-info
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |